Clinical Collaboration

Selected news for the healthcare topic - Clinical Collaboration, collected since 10/2017. Recent stories appear in Globe Newswire and rivertonroll.com. This healthcare topic shares news with Merck, Bristol-Myers, Bristol-Myers Squibb, Gilead, Prostate Cancer and over a hundred others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
7/9/2021 Critical Flaws Reported in Philips Vue PACS Medical Imaging Systems thehackernews.com Multiple security vulnerabilities have been disclosed in Philips Clinical Collaboration Platform Portal (aka Vue PACS), some of which could be exploited by an adversary to take control of an affected system. "Successful exploitation of these vulnerabilities could allow an unauthorized person or process to eavesdrop, view or modify data, gain system access, perform code execution, install unauthorized software, or affect system data integrity in such a way as to negatively ...
7/9/2021 Critical Flaws Reported in Philips Vue PACS Medical Imaging Systems – Tu Cloud Server tucloudserver.com Various protection vulnerabilities have been disclosed in Philips Clinical Collaboration System Portal (aka Vue PACS), some of which could be exploited by an adversary to choose handle of an affected technique.“Productive exploitation of these vulnerabilities could enable an unauthorized particular person or process to eavesdrop, perspective or modify info, attain procedure obtain, accomplish code execution, set up unauthorized computer software, or have an effect on method data integrity in ...
7/4/2021 Beam Therapeutics (NASDAQ:BEAM) and Aerie Pharmaceuticals (NASDAQ:AERI) Critical Contrast thelincolnianonline.com ... develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children's Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.Aerie Pharmaceuticals Company ...
6/29/2021 Arbutus Biopharma and Antios Therapeutics Announce Clinical Collaboration Agreement to Evaluate AB-729 in Combination with ATI-2173 in Subjects with Chronic Hepatitis B Virus Infection Globe Newswire MENDHAM, N.J. and WARMINSTER, Pa., June 29, 2021 (GLOBE NEWSWIRE) -- Antios Therapeutics, Inc. and Arbutus Biopharma Corporation (Nasdaq: ABUS) today announced that the companies have entered into a clinical collaboration agreement to evaluate a triple combination of Arbutus’ proprietary GalNAc delivered RNAi therapeutic, AB-729, Antios’ proprietary active site polymerase inhibitor nucleotide (ASPIN), ATI-2173, and Viread (tenofovir disoproxil fumarate), for the treatment of subjects with chronic hepatitis ...
6/22/2021 Cornell clinical collaboration with Kazia to study glioblastoma drug techtransfercentral.com University-Industry Engagement Advisor Current Issue Ad Cornell clinical collaboration with Kazia to study glioblastoma drug By David SchwartzPublished: June 22nd, 2021 Cornell University’s Weill Medical College has entered a clinical collaboration with Australia-based oncology drug developer Kazia Therapeutics Ltd. to launch a phase II clinical study investigating the use of paxalisib – the company’s investigational new drug – to treat glioblastoma. The ...
6/17/2021 Talaris Therapeutics (NASDAQ:TALS) versus Beam Therapeutics (NASDAQ:BEAM) Critical Analysis slatersentinel.com ... develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children's Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.About Talaris Therapeutics ...
6/17/2021 Financial Review: Beam Therapeutics (NASDAQ:BEAM) vs. Talaris Therapeutics (NASDAQ:TALS) rivertonroll.com ... develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children's Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.About Talaris Therapeutics ...
6/10/2021 ALX Oncology to Collaborate with Lilly to Evaluate ALX148 Plus CYRAMZA® (Ramucirumab), Trastuzumab, and Paclitaxel in Patients with Gastric or Gastroesophageal Junction Cancer Globe Newswire ... paclitaxel for the treatment of patients whose tumors have progressed following treatment with HER2-targeted therapy and chemotherapy. Lilly will supply ramucirumab for this trial. Financial details of the collaboration agreement are undisclosed.This clinical collaboration is based on compelling data from the ongoing ASPEN-01 Phase 1b trial in patients with HER2-positive gastric or gastroesophageal junction cancer who had progressed on one or more lines of trastuzumab therapy ...
6/7/2021 SpringWorks Therapeutics Announces Clinical Collaboration with Seagen to Evaluate Nirogacestat in Combination with SEA-BCMA in Patients with Relapsed or Refractory Multiple Myeloma firstwordpharma.com ... intellectual property rights. Seagen and SpringWorks will also form a joint development committee to manage the clinical study, which is expected to commence in the second half of 2021.In addition to its ongoing clinical collaborations with BCMA-directed therapies, SpringWorks is conducting a global Phase 3, double-blind, randomized, placebo-controlled clinical trial (the DeFi Trial) to evaluate nirogacestat as a monotherapy in adults with progressing desmoid tumors.About ...
5/26/2021 Reviewing Beam Therapeutics (NASDAQ:BEAM) and Applied Genetic Technologies (NASDAQ:AGTC) rivertonroll.com ... develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children's Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.About Applied Genetic ...
5/18/2021 DrFirst Honors Industry Leaders for Excellence in Using Healthcare Technology to Improve Care Collaboration, Interoperability, and Patient Outcomes PR Newswire ROCKVILLE, Md. , May 18, 2021 /PRNewswire/ -- Health technology pioneer DrFirst today announced the winners of its inaugural Healthiverse Heroes Award , honoring healthcare providers and organizations that are breaking through information silos that stand in the way of clinical collaboration and patient care."Forward-thinking providers and organizations have taken extraordinary measures during the pandemic to find ways to shatter barriers to clinical collaboration and ensure patients receive the best possible ...
5/18/2021 marylandlatinonews marylandlatinonews.com ... 18, 2021 /PRNewswire/ -- Health technology pioneer DrFirst today announced the winners of its inaugural Healthiverse Heroes Award , honoring healthcare providers and organizations that are breaking through information silos that stand in the way of clinical collaboration and patient care."Forward-thinking providers and organizations have taken extraordinary measures during the pandemic to find ways to shatter barriers to clinical collaboration and ensure patients receive the best possible care," said G ...
5/18/2021 St. Luke's University Health Network's journey to a new clinical communication and collaboration platform — insights and lessons learned Becker's Hospital Review ... staff often covered multiple hospitals and used disparate coverage scheduling systems. They relied on manual, time-consuming processes like calling the operator and waiting on hold. To identify the foundational requirements for self-service clinical collaboration and communication, the St. Luke's innovation team looked at the big picture. They evaluated the telecommunications infrastructure as well as human resources and governance policies. "Economies of scale and the associated benefits can only ...
5/17/2021 Zentalis Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Update Globe Newswire ... York, UNITED STATES Reported robust initial results from the Phase 1 monotherapy dose escalation trial of its WEE1 inhibitor, ZN-c3, demonstrating single-agent activity and Exceptional Responses in heavily pre-treated patients Announced clinical collaboration with GlaxoSmithKline (GSK) to evaluate ZN-c3 in combination with niraparib, a PARP inhibitor Upcoming milestone review of its clinical product candidates ZN-c5 and ZN-c3NEW YORK and SAN DIEGO, May 17 ...
5/17/2021 Psychotherapist – Wildflower Center for Emotional Health LLC – Chicago, IL medacura.com ... for candidates who live values that animate our group: integrity, compassion, collaboration, authenticity, and growth-mindedness.Psychotherapy at Wildflower is grounded in empirically-based modalities and theories as well as focus on learning and clinical collaboration to provide the highest quality of attuned, empathic care. We serve individuals, couples, and families and center our practice on these key areas: reproductive mental health and parenting, mood and anxiety, trauma, sexuality, and ...
5/15/2021 Global Oncology Drugs Market – Competitive Analysis Estimations, Business Competitors, Cost Structure, Key Companies and Forecast to 2027 themarketpublicist.com ... 39.1 Bn and US$ 11.5 Bn respectively. Roche is at the forefront of cancer immunotherapy with ten investigational drug candidates currently in the clinical development phase. In 2016, the company entered into 10 new clinical collaboration agreements to explore drug combinations for maximizing therapeutic benefits and develop the lead immunotherapy drug. The company has set up imCORE, a network of 21 academic institutions working with Roche to advance research into ...
5/14/2021 Contrasting Vir Biotechnology (NASDAQ:VIR) & Taysha Gene Therapies (NASDAQ:TSHA) baseballnewssource.com ... Development Limited, GlaxoSmithKline Biologicals SA., and Alnylam Pharmaceuticals, Inc. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies for potential COVID-19 treatment; and clinical collaboration with Gilead Sciences, Inc. for chronic hepatitis B virus. Vir Biotechnology, Inc. was founded in 2016 and is headquartered in San Francisco, California.About Taysha Gene TherapiesTaysha Gene Therapies, Inc., a gene therapy ...
5/12/2021 Context Therapeutics® and Jefferson Health Announce First Patient Dosed in Phase 2 Trial of ONA-XR in Advanced Endometrial Cancer Globe Newswire ... Cancer Center – Jefferson Health, today announced the first patient has been dosed in the Phase 2 ONWARD 221 trial in patients with metastatic endometrial cancer.The trial, sponsored by Jefferson Health, is a clinical collaboration between Context and Jefferson Health’s Sidney Kimmel Cancer Center (SKCC) to evaluate the effect of the addition of progesterone receptor (PR) antagonist onapristone extended release (ONA-XR) to the antiestrogen, anastrozole, on outcomes ...
5/9/2021 Beam Therapeutics (NASDAQ:BEAM) versus CRISPR Therapeutics (NASDAQ:CRSP) Head-To-Head Comparison baseballnewssource.com ... develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children's Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.About CRISPR Therapeutics ...
5/6/2021 ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2021 Yahoo News ... expect to provide a clinical update in the fourth quarter of this calendar year," said Dr. David R. Parkinson , M.D., President and Chief Executive Officer of ESSA Pharma. "During the quarter, we also announced clinical collaboration s with Janssen and Astellas, and recently on April 28 th entered into a partnership with Bayer, all focused on evaluating EPI-7386 in Phase 1/2 clinical studies in combination with their respective anti-androgen ...